The accumulation of abnormal Tau in the human brains has been implicated in major neurodegenerative diseases termed tauopathies, including Alzheimer’s disease (AD), Parkinson’s disease (PD), frontotemporal dementia with Parkinsonism-17 (FTDP-17), and so on [1–3]. This evidence concerns the gene MAPT and Parkinson disease.